Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mantra Bio logo — Mantra Bio is harnessing exosomes to deliver safe, highly ta...

Mantra Bio

Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines.

Founded 2016 United States South San Francisco, United States 14 employees Series A Total: $34.00M Biotechnology, Life Sciences

General Information

Company Name Mantra Bio
Founded Year 2016
Location United States South San Francisco, United States +1
Employees 14
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

Get notified when Mantra Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mantra Bio

Mantra Bio is a biotechnology startup founded in 2016 and based in the United States. The company's slogan, "Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines," reflects its focus on utilizing exosomes for precise drug delivery. Their flagship product, REVEAL™, is an exosome engineering platform that integrates computational biology and lab automation to produce targeted exosome vehicles (TEVs) for various therapeutic areas. Their latest funding round, a $9.00M Series A investment, attracted a consortium of notable investors including BoxGroup, 8VC, Allen & Company, Samsung Securities, Viking Global Investors, and Illumina, demonstrating strong support from prominent players in the industry. Mantra Bio's innovative approach to leveraging exosomes for drug delivery positions the company at the forefront of advancements in the life sciences sector.

Taxonomy: exosome delivery, targeted medicines, REVEAL platform, computational biology, lab automation, biomanufacturing, therapeutics, novel drug delivery, engineered exosomes, precision medicine, biomedical engineering

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		04 Jan 2023
Series A •••••• 4
Investor Investor Investor Investor
29 Jul 2020
Series A •••••• - 19 Nov 2019

Mantra Bio Alternatives & Competitors

Mantra Bio vs
Exopharm Ltd
Exopharm Ltd Australia

Delivering Transformative Medicines

5 employees
Biopharma, Biotechnology
Mantra Bio vs
ReNeuron Group Plc
ReNeuron Group Plc United Kingdom

Developing the next generation of Engineered Exosomes.

Post Ipo Equity
27 employees
Biotechnology, Health Care
Compare Mantra Bio vs ReNeuron Group Plc
Mantra Bio vs
Rosetta Exosome Co., Ltd.
Rosetta Exosome Co., Ltd. Korea South

The Exosome Company, reinventing the future with exosome.

Series A
6 employees
Health Care, Medical Devices

FAQ About Mantra Bio

Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines.
Mantra Bio was founded in 2016.
Mantra Bio is headquartered in South San Francisco, United States.
Mantra Bio operates in the following industries: Biotechnology, Life Sciences.
Mantra Bio has approximately 14 employees.
Mantra Bio has completed 3 funding rounds, raising a total of $34.00M. The latest funding stage is Series A.
Top alternatives and competitors to Mantra Bio include Exopharm Ltd, ReNeuron Group Plc, Rosetta Exosome Co., Ltd., Evox Therapeutics Ltd, Primoris Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mantra Bio and Exopharm Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mantra Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy